Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Moiola

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Molecular Psychiatry|November 30, 2023
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosusMor Gueye, Paolo Preziosa, Giuseppe A Ramirez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2015
Myeloid cells as target of fingolimod action in multiple sclerosisMarco Di Dario, Emanuela Colombo, Chiara Govi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Brain : a Journal of Neurology|April 8, 2021
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromesMarco Pisa, Tommaso Croese, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Journal of Personalized Medicine|January 21, 2023
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine ApproachLaura Ferrè, Ferdinando Clarelli, Beatrice Pignolet, et al.
Expert Opinion on Drug Delivery|March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER studyDamiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2024
Vitamin D affects the risk of disease activity in multiple sclerosisAntonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Molecular Psychiatry|November 30, 2023
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosusMor Gueye, Paolo Preziosa, Giuseppe A Ramirez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2015
Myeloid cells as target of fingolimod action in multiple sclerosisMarco Di Dario, Emanuela Colombo, Chiara Govi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Brain : a Journal of Neurology|April 8, 2021
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromesMarco Pisa, Tommaso Croese, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Journal of Personalized Medicine|January 21, 2023
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine ApproachLaura Ferrè, Ferdinando Clarelli, Beatrice Pignolet, et al.
Expert Opinion on Drug Delivery|March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER studyDamiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2024
Vitamin D affects the risk of disease activity in multiple sclerosisAntonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, et al.
Pageof 16